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http://dx.doi.org/10.1016/j.fjs.2013.Summary Synovial sarcomas are highly aggressive soft tissue malignant tumors that occur pri-
marily in young adults. They arise from mesenchymal tissue and typically in or near tendons and
tendon sheaths. They can develop at any site but the majority (80e95%) of synovial sarcomas are
located in the extremities and mostly at the lower extremities. Groin synovial sarcoma is rare.
About 10% of lower limb soft tissue sarcomas have major vessel involvement. In the past, ampu-
tation was the standard surgical procedure for lower limb soft tissue sarcoma with major vessels
involvement. However, using modern surgical techniques, we can successfully perform a limb-
preserving operation with a tumor-free margin. A 17-year-old girl presented with left inguinal
synovial sarcoma with femoral artery and vein encasement. The patient received radical tumor
resection with major vascular structures. Segmental femoral vessel defects were reconstructed
with polytetrafluoroethylene grafts. After revascularization, we designed a pedicled anterolat-
eral thigh fasciocutaneous flap for coverage of the wound and reconstructed vessels simulta-
neously. The circulation of the lower extremity was good and the girl recovered well after the
surgery without morbidity. Synovial sarcoma would potentially be associated with local recur-
rence and distant metastasis. The presences of bone and neurovascular bundle invasion are
adverse predictors of recurrence and mortality. Surgery remains the mainstay of treatment. In
the advance of current surgical technique, limb-preserving surgery is possible even for tumor-
involved major vessels.
Copyright ª 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.have no conflicts of interest relevant to this article.
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Groin synovial sarcoma with femoral sheath 371. Introduction
decided to use a synthetic graft with polytetrafluoro-Soft tissue sarcomas account for approximately 1% of ma-
lignant tumors. Most of them arise from the extremities,
followed by the trunk wall, retroperitoneum, and head and
neck.1 Synovial sarcoma is an aggressive subtype2 that oc-
curs primarily in young adults.3,4 The term “synovial” is
derived from its morphologic origin and its histological
resemblance, and is easily misinterpreted to mean that the
tumor comes from synovium.5 However, it is a mesen-
chymal tumor.2
The majority of the tumors appear in the extremities,
with two-thirds being located in the lower extremities.2,5
The most common site is within 10 cm of the knee. Extra-
articular is dominant and true intra-articular tumor is
very rare.2 It presents as a slow-growing, frequently painful
tumor.2,3 The current standard treatment is wide resection
of the tumor, followed by irradiation with or without
chemotherapy.5 Initial adequate radical ablation surgery is
still the most important tumor-free prognosis factor.
When soft tissue sarcomas in the extremities involve
major vessels, it may become a challenge to achieve a clear
margin. In the past, amputation was the mainstay to obtain
a cancer-free margin. Here, we report a case of groin sy-
novial sarcoma that encased the femoral vasculature. We
cooperated with vascular surgeons for a tumor wide exci-
sion and vascular segmental resection followed by vascular
reconstruction and pedicled anterolateral thigh flap
reconstruction for vessel and soft tissue defect.2. Case report
A 17-year-old girl was in a healthy condition previously. She
presented to our outpatient clinic due to a small palpable
mass in the left groin area noticed for 2 months, which
enlarged gradually. She denied recent trauma to the
affected extremity. Physical examination revealed an
elastic, firm, and fixed tumor, which was 10 cm in diameter.
Its palpation provoked minimal discomfort without numb-
ness or tenderness. Her lower extremity range of motion
and muscular strength were normal. Magnetic resonance
imaging also revealed a heterogenous tumor both on T1WI
and T2WI images at the groin area with contrast enhance-
ment. It also revealed septation and central necrosis.
Femoral vessels were wrapped by the tumor (Fig. 1). An
incisional biopsy was then performed and the final histo-
logic diagnosis was synovial sarcoma. Further oncological
surveillance to evaluate distant metastasis, such as bone
scan, chest computed tomography, and chest X-ray all ruled
out metastasis. A tumor wide excision was then planned
and possible vascular resection will be needed. Due to the
indispensability of the femoral artery for the lower ex-
tremity, further vascular reconstruction was necessary.
An oncological resection with a cutaneous peripheral
safe margin of 2 cm was designed (Fig. 2). Deep plane as far
as the rectus femoris muscle fascia was included, sent for
frozen section intraoperatively, and revealed to be free of
tumor cells. The tumor encased the femoral artery and
veins at the arterial bifurcation site, and the femoral nerve
was spared (Fig. 3). The involved and estimated resectionvascular length measured 11 cm. The vascular surgeon
ethylene (PTFE) for vascular reconstruction. A 6 mm PTFE
graft was first used to make a Y-shaped graft in the back
table for arterial reconstruction. We did tumor en bloc
resection with femoral artery and vein segmental resec-
tion. The lower extremity became cold and poorly circu-
lated, so the vascular surgeon started revascularization.
The Y-shaped PTFE graft is anastomosis from the femoral
artery to the deep femoral artery and superficial artery.
Another 8 mm graft was used for vein reconstruction from
the proximal femoral vein to distal femoral vein (Fig. 4). No
intraoperative heparin was administered. After revascu-
larization, the lower extremity became warm and well
circulated. An ipsilateral pedicled anterolateral thigh flap
was then designed for resultant inguinal soft tissue defect
reconstruction. The pedicled anterolateral thigh flap with
skin paddle sized 15 cm  9 cm with two musculocutaneous
perforators, based on the lateral circumflex branch of
femoral artery, was harvested (Fig. 4AeC). Partial tensor
fascial lata was also included. The flap was rotated through
the subcutaneous tunnel to reach the inguinal defect
(Fig. 4D). A fascial lata was used for inguinal deep fascia
reconstruction and repaired with 1-0 Surgilon (Covidien).
The flap donor site was covered with a split-thickness skin
graft harvested from the medial thigh.
Neither anticoagulant agent nor antiplatelet therapy
were given postoperatively. The circulation of the flap and
lower extremity were good. The patient was discharged
uneventfully.
2.1. Outcome
The biopsy specimen grossly revealed a tumor cell
intramural invasion (Fig. 5). The final pathology report
confirmed synovial sarcoma, biphasic type, with free
margins and local regional lymph nodes were negative of
malignancy. Pathological pictures revealed spindle-
shaped neoplastic cells and focal epithelial components
with glandular formation. Vascular invasion and emboli
were also noted. Immunohistochemically, both the spindle
and epithelial components were positive for epithelial
membrane antigen (Fig. 6). Adjuvant radiotherapy and
chemotherapy were suggested, but the patient and her
parents refused radiotherapy. Therefore, chemotherapy
with epirubicin and cisplatin were started 1 month after
the operation. Six courses of chemotherapy were applied
until abandoned at the patient’s wish. During follow-up
for 14 months, neither lower limb swelling, synthetic
graft thrombosis, nor wound infection were detected
(Fig. 7).
3. Discussion
Synovial sarcomas are malignant soft tissue sarcomas
comprising approximately 6e9% of all adult soft tissue
sarcomas. There is a wide age range at presentation, but
young adults are affected most often.6 There is no sex
predilection. It can develop in any anatomical site; how-
ever, the extremities are the most common sites and the
majority occur in the lower extremities. It mostly develops
Figure 1 Magnetic resonance imaging revealed a heterogeneous tumor, 50 mm 48 mm, located in the groin region characterized
by septation, central necrosis, and encased femoral neurovascular bundle with femoral vessel intraluminal invasion (arrow).
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involvement.7 Synovial sarcomas have been shown to
develop nodal metastases more frequently than other soft
tissue sarcomas, with an incidence of 10e12%.Figure 2 Perioperative picture shows an elevated, firm
tumor over the groin area. Oncological resection with a 2-cm
safe margin was then designed for a tumor wide excision.Despite its name, synovial sarcoma is not derived from
synovial tissue. The name is derived from its microscopic
resemblance to synovium. It is considered a high-grade
sarcoma and is composed of two morphologically distinct
cell types: spindle cells and epithelioid cells. These cells
are in various proportions leading to classification into
three subtypes: biphasic, monophasic, and poorly differ-
entiated.3 Synovial sarcomas consistently stain positive
for cytokeratin and epithelial membrane antigen. These
markers are strongly positive for epithelial components and
patchy staining can help distinguish from carcinomas. Bcl-2
is positive in synovial sarcoma and was thought to be unique
at first, but other nerve sheath tumors also presented Bcl-2
positive. S100 and CD99 are also positive in synovial sar-
coma but also would be confused with Ewing’s sarcoma or
malignant peripheral nerve sheath tumor. Other antibodies,
actins (muscle-specific actin, a-smooth muscle actin),
desmin, CD34, and CD31 are negative in synovial sar-
coma.3,6 In our case, the spindle and epithelial components
were positive for cytokeratin and epithelial membrane
antigen, and negative for desmin. Those characteristics are
compatible with synovial sarcoma.
In molecular genetics, most synovial sarcomas (90%)
demonstrate a specific translocation between chromosome
X and chromosome 18 (p11.2; q11.2). This includes the SYT
gene on chromosome 18 and one of several homologous
genes (SSX1, SSX2, and SSX4) on the X chromosome. This
leads to the expression of the unique SYT/SSX fusion pro-
tein in all cases of synovial sarcoma, which suggests a
crucial role of the fusion protein in the etiology of this
tumor.3,6
Clinically, the patient typically presents with a slow-
growing mass that may grow over weeks to months. Deeper
lesions, which are difficult to detect, may become very
large. The groin area is a rare anatomical site for the tumor.
In a study reported by St Jude Hospital in 2009, among 300
nonrhabdomyosarcoma soft tissue sarcoma young patients,
Figure 3 Intraoperative picture showing the tumor-encased
femoral artery and vein at the arterial bifurcation region and
to such an extent that dissection to free them was impossible.
The femoral nerve was spared.
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Image studies can appear as multilobular, septated
masses that show heterogenous signal intensity on T1WI and
T2WI on magnetic resonance imaging. Heterogenous
contrast enhancement is caused by central necrosis, cal-
cifications, and hemorrhage within the tumor.1 Three
components are classically described: cellular with anFigure 4 (A) Ipsilateral pedicled anterolateral thigh flap with skin
(B) The vascular surgeon used a synthetic polytetrafluoroethylene
the back table for arterial reconstruction. Another straight graf
locutaneous perforators, based on revascularized lateral circumflex
was rotated through the rectus femoris muscle to the inguinal regintermediate signal; necrotic or hemorrhage with a high
signal; fibrous or calcified with a hypointensity, and this is
known as the “triple sign”.2,7,9 Slow growth of the tumor
can result in superficial pressure cortical erosion, periosteal
reaction, and osteoporosis.2
The primary treatment of synovial sarcoma is surgery,
comprising wide excision with negative margins. It should
be carried out through normal adjacent tissue planes.
Adjuvant radiotherapy is considered helpful for local
recurrence control. Synovial sarcoma demonstrates mod-
erate chemosensitivity and approximately 50% response
rate due to doxorubicin-based regimens.10
Synovial sarcomas involving major vessels, such as the
axillary artery and femoral artery were thought unresect-
able in the past.11 In a review of the literature, only 5e10%
of soft tissue sarcoma infiltrated or encased vascular
structures.12 Historically, amputation of limbs was consid-
ered the only resolution to obtain negative surgical mar-
gins. With the advancement of operative technique and
available grafts, limb preservation with tumor and vascular
en bloc resection and reconstruction with saphenous vein
graft, femoral venous grafts, or synthetic grafts can be
achieved.12 The first description of sarcoma resection in the
extremity with arterial replacement was reported by
Fortner et al13 in 1977. There were several studies showing
that limb salvage combined with vascular reconstruction
offers rates of local control and overall survival that are
comparable to amputation.14 Estimation of resection length
is based on a preoperative image study, which is helpful for
identifying the appropriate graft to choose.15 In a largepaddle 15 cm  9 cm designed for soft tissue defect coverage.
graft for vascular reconstruction and made a Y-shaped graft in
t was used for femoral vein reconstruction. (C) Two muscu-
branch of the deep femoral artery were included. (D) The flap
ion.
Figure 5 The biopsy specimen reveals tumor thrombi with
intraluminal invasion (arrow).
Figure 7 Eight months after the surgery, the patient recov-
ered well and no lower limb swelling, graft thrombosis, or
wound infection were found. She could ambulate without
difficulty.
40 P.-J. Lee et al.series presented by Schwarzbach et al11 in 2005, in the
iliofemoral and femoropopliteal region above the knee,
they used predominantly synthetic grafts for arterial
reconstruction. This can reduce operative time and pre-
serve the greater saphenous vein (GSV). Long-term patency
rates between the synthetic graft and autologous graft
were identical. The venous reconstruction protocol is
controversial. Some studies suggest that if ipsilateral GSV is
preserved and patent, the remaining femoral vein stumps
could be ligated. However, if the GSV is sclerotic or
resected together, reconstruction should be performed.
Recently, however, venous reconstruction is associatedFigure 6 (A) Hematoxylin and eosin stain, 40: vascular invasion
section shows a sheet of spindle-shaped neoplastic cells and focal
histochemistry, 100: epithelial membrane antigen positive. (D) I
ponents are positive for epithelial membrane antigen.with better outcome, and less morbidity such as extremity
swelling, seroma formation, and wound infection is seen. In
Schwarzbach et al’s11 series, venous patency rate was
54.9% with PTFE graft reconstruction. Due to the rapidwith tumor emboli. (B) Hematoxylin and eosin stain, 100: this
epithelial components with glandular formation. (C) Immuno-
mmunohistochemistry, 400: both spindle and epithelial com-
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bypass several weeks after surgery usually would not
require a second revision operation. In our case, we per-
formed both arterial and venous reconstruction with syn-
thetic grafts due to the long segment of vascular and
complicated soft tissue defect. Cautious administration of
low-dose heparin intraoperatively is sufficient for occlusion
prophylaxis. Further oral form anticoagulant or antiplatelet
therapy was prescribed only for selected patients.16 The
added risk of complications (primarily bleeding) with
vascular procedures performed on patients treated with
aspirin is measurable.17,18 In our case, no heparin injection
or postoperative anticoagulant and antiplatelet therapy
were given because the girl was young and medically
healthy without such myocardial or cerebral risk factors.
After 8 months, no sequelae of lower limb swelling, circu-
lation compromised, or wound infection occurred. Adjuvant
radiotherapy may have potential adverse effects on the
reconstructed graft, such as occlusion or arterial blowout.
A radiation dose exceeding 50 Gy can induce vessel wall
abnormality. Nevertheless, there is still no published series
about the effect of radiotherapy and extremity vascular
reconstruction following a sarcoma surgery.
Approximately 25% of patients have metastases at pre-
sentation, frequently to the lung. Other common meta-
static sites include bone and lymph nodes. In the literature,
5-year survival ranges from 25% to 60%. Multiple studies
have identified prognostic factors and these predictive
values remain controversial and constantly evolving.9,19
Incidence of metastases at diagnosis was thought to have
a strong correlation to poor prognosis. Tumor size greater
than 5 cm has a significant correlation to survival.19 In
primary extremity synovial sarcomas that are larger than
5 cm, distant metastasis rate is over 50% and resultant 5-
year tumor-related mortality is almost 40%. Tumor invasion
of adjacent bone, nerve, and vascular structures are also
adverse prognostic predictors. From the molecular genetics
aspect, many studies also highlight a worse prognosis for
patients with the SYT/SSX1 translocation than those with
SYT/SSX2 translocations.4,20
In conclusion, synovial sarcoma is an uncommon high-
grade soft tissue sarcoma. It is prevalent in young adults
and occurs near joints. It has a high tendency for local
recurrence and distant metastasis if major vessels are
involved. First-time surgical procedure of radical wide
excision with enough clear margins has significantly
improved the prognosis. With the advance of current sur-
gical techniques, limb-preserving surgery is feasible even
when intramural invasion is diagnosed.
We herein presented a case with rare groin synovial
sarcoma with intramural femoral vessels involvement;
limb-preserving surgery, including complex vascular and
soft tissue reconstruction, was performed successfully.
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